A detailed history of Goldman Sachs Group Inc transactions in Organon & Co. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 614,491 shares of OGN stock, worth $9.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
614,491
Previous 915,053 32.85%
Holding current value
$9.05 Million
Previous $18.9 Million 37.94%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.65 - $23.03 $5.61 Million - $6.92 Million
-300,562 Reduced 32.85%
614,491 $11.8 Million
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $6.35 Million - $7.99 Million
363,630 Added 65.94%
915,053 $18.9 Million
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $1.81 Million - $2.48 Million
131,666 Added 31.37%
551,423 $10.4 Million
Q4 2023

Feb 13, 2024

SELL
$10.95 - $17.32 $11.9 Million - $18.9 Million
-1,088,678 Reduced 72.17%
419,757 $6.05 Million
Q3 2023

May 14, 2024

BUY
$16.59 - $23.77 $18.1 Million - $25.9 Million
1,088,678 Added 259.36%
1,508,435 $26.2 Million
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $11.3 Million - $16.2 Million
-682,048 Reduced 31.14%
1,508,435 $26.2 Million
Q2 2023

May 14, 2024

BUY
$19.27 - $24.63 $28 Million - $35.8 Million
1,453,728 Added 197.31%
2,190,483 $45.6 Million
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $28 Million - $35.8 Million
1,453,728 Added 197.31%
2,190,483 $45.6 Million
Q1 2023

May 14, 2024

BUY
$21.42 - $32.08 $7.96 Million - $11.9 Million
371,567 Added 101.75%
736,755 $17.3 Million
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $7.96 Million - $11.9 Million
371,567 Added 101.75%
736,755 $17.3 Million
Q4 2022

May 14, 2024

SELL
$23.31 - $28.61 $5.39 Million - $6.62 Million
-231,313 Reduced 38.78%
365,188 $10.2 Million
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $5.39 Million - $6.62 Million
-231,313 Reduced 38.78%
365,188 $10.2 Million
Q3 2022

May 14, 2024

BUY
$23.4 - $34.25 $1.55 Million - $2.27 Million
66,299 Added 12.5%
596,501 $14 Million
Q3 2022

Nov 10, 2022

BUY
$23.4 - $34.25 $1.55 Million - $2.27 Million
66,299 Added 12.5%
596,501 $14 Million
Q2 2022

May 14, 2024

BUY
$31.66 - $38.9 $3.5 Million - $4.3 Million
110,445 Added 26.31%
530,202 $17.9 Million
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $20.2 Million - $24.8 Million
-636,522 Reduced 54.56%
530,202 $17.9 Million
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $12.4 Million - $16.1 Million
408,618 Added 53.9%
1,166,724 $40.8 Million
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $14.9 Million - $19.3 Million
-518,838 Reduced 40.63%
758,106 $23.1 Million
Q3 2021

Nov 10, 2021

BUY
$28.63 - $35.64 $36.6 Million - $45.5 Million
1,276,944 New
1,276,944 $41.9 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.